CARE Ratings Ltd Gains 2.09%: Technical Upgrades and Strong Financials Drive Momentum

3 August: Modest Start Amid Positive Market Momentum

CARE Ratings Ltd began the week at Rs.1,713.80, marking a slight increase of 0.20% from the previous Friday’s close of Rs.1,710.30. This modest gain came alongside a robust Sensex rally of 0.82%, closing at 36,985.17. The stock’s volume of 2,979 shares indicated steady investor interest. The price traded within a range that remained comfortably above the 52-week low of Rs.1,393.95, signalling underlying support despite broader market volatility.

4 August: Technical Momentum Shifts and Rating Upgrade

On 4 August, CARE Ratings’ technical momentum shifted decisively towards bullishness, prompting MarketsMOJO to upgrade its Mojo Score to 71.0 and revise the rating from Hold to Buy. The stock closed at Rs.1,726.55, up 0.74% on the day, even as the Sensex dipped slightly by 0.14% to 36,933.47. Key technical indicators such as the weekly MACD and daily moving averages supported this positive shift, while Bollinger Bands on weekly and monthly charts indicated expanding upward volatility.

Financially, the company’s strong Q4 FY25-26 results underpinned this upgrade. CARE Ratings reported a 28.77% growth in Profit Before Tax excluding other income, reaching Rs.56.30 crores for the quarter, alongside a robust Return on Capital Employed of 24.81% for the half-year. Institutional investors held a significant 54.99% stake, reflecting confidence from sophisticated market participants.

5 August: Bullish Momentum Strengthens on Strong Returns

The bullish momentum continued on 5 August, with CARE Ratings closing at Rs.1,745.35, a 1.09% gain from the previous day. This outpaced the Sensex’s 0.38% rise to 37,074.66. The stock’s intraday high of Rs.1,751.00 and volume of 3,485 shares reflected healthy trading activity. Technical indicators remained supportive: the weekly MACD stayed bullish, daily moving averages confirmed the uptrend, and On-Balance Volume (OBV) trends were positive on both weekly and monthly charts, signalling strong buying interest.

Despite the monthly MACD and Know Sure Thing (KST) indicators remaining mildly bearish, the overall technical picture favoured short-term gains. The Relative Strength Index (RSI) hovered in neutral territory, suggesting the stock was neither overbought nor oversold, allowing room for further appreciation.

6 August: Minor Correction Amid Broader Market Gains

On 6 August, CARE Ratings experienced a minor pullback, closing at Rs.1,728.85, down 0.95% from the previous day’s close. This decline contrasted with the Sensex’s 0.28% gain to 37,177.57, indicating a brief divergence from broader market strength. The stock’s volume decreased to 1,786 shares, reflecting reduced trading activity. The correction may be attributed to profit-taking or caution prompted by the mildly bearish monthly momentum indicators and mixed Dow Theory signals.

7 August: Week Closes Strong with Consolidation

CARE Ratings rebounded on the final trading day of the week, closing at Rs.1,746.10, up 1.00% on the day, while the Sensex declined 0.21% to 37,099.57. The stock’s volume of 1,878 shares suggested steady investor interest. This close near the week’s high reinforced the short-term bullish trend and the positive technical upgrade earlier in the week. The stock’s weekly gain of 2.09% notably outperformed the Sensex’s 1.13% rise, underscoring its relative strength.

Key Takeaways

Positive Signals: CARE Ratings demonstrated strong short-term technical momentum, supported by bullish daily moving averages, weekly MACD, and expanding Bollinger Bands. The upgrade to a Buy rating by MarketsMOJO reflects confidence in the company’s robust financial performance, including a 28.77% quarterly profit growth and a high Return on Capital Employed of 24.81%. Institutional ownership near 55% adds credibility and stability to the stock’s outlook. The stock’s consistent outperformance relative to the Sensex over multiple timeframes highlights its resilience and appeal within the capital markets sector.

Cautionary Notes: Despite short-term strength, monthly momentum indicators such as the MACD and Know Sure Thing (KST) remain mildly bearish, signalling potential headwinds over longer horizons. The mixed Dow Theory readings and absence of a clear volume trend on some days suggest that gains may face resistance or consolidation phases. The stock’s premium valuation, with a Price to Book ratio of 5.5 and a PEG ratio of 1.3, warrants careful monitoring to ensure growth justifies current pricing.

Conclusion

CARE Ratings Ltd’s performance during the week ending 7 August 2026 reflects a stock in transition, with a clear shift towards bullish momentum supported by strong financial results and technical upgrades. The 2.09% weekly gain outpaced the Sensex’s 1.13% rise, underscoring the stock’s relative strength. While short-term indicators and institutional backing provide a solid foundation for further gains, mixed monthly signals and valuation considerations counsel a balanced approach. Investors should continue to monitor momentum indicators and volume trends closely to gauge the sustainability of the current uptrend.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today